Rapid Medical has announced CE mark approval for Tigertriever XL stentriever. The company noted that the first patients have been treated successfully with the neurovascular device.
According to the company, the device is the latest addition to the Tigertriever family of stentrievers, which are adjustable, fully visible clot retrievers designed to treat ischemic stroke. The Tigertriever XL features a length of 53mm and an adjustable diameter that can conform to any vessel diameter up to 9mm. It is delivered via a standard microcatheter with an internal diameter of 0.021 inches.
“Tigertriever XL is a very important addition to the ischemic stroke market,” commented Sebastian Fischer, senior Interventional Neuroradiologist at Bochum University Hospital, Germany, in the company’s announcement.
He continued: “For the first time, we have a tool that can be adjusted to these dimensions and is dedicated to retrieving large clot loads. This is an important addition to our current toolset since it can potentially reduce the number of passes required to remove large stroke-causing clots, for example, in the internal carotid artery.”
The post Rapid Medical’s Tigertriever XL receives CE mark approval appeared first on NeuroNews International.